A randomized comparison of two instruments for measuring self-reported antiretroviral adherence

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 20, Issue 2, 2008, Pages 161-169

  Mannheimer, S ^a,j   Thackeray, L ^b   Hullsiek, K Huppler ^b   Chesney, M ^c   Gardner, E M ^d   Wu, A W ^e   Telzak, E E ^f   Lawrence, J ^g   Baxter, J ^h   Friedland, G ⁱ  

^a Division of Infectious Diseases ^*  (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d UNIVERSITY OF COLORADO   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h Department of Anesthesiology   (United States)

ⁱ YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j Och Spine at New York Presbyterian Hospitals   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS RNA;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESPONSE; DRUG TREATMENT FAILURE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERMETHOD COMPARISON; MALE; MULTIDRUG RESISTANCE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RECALL; SELF REPORT; TIME; VIRUS MUTATION;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; RESEARCH DESIGN; SELF ADMINISTRATION;

EID: 43249083005     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540120701534699     Document Type: Article

References (29)

1. Arnsten, J., Demas, P., Farzadegan, H., Grant, R., Gourevitch, M., Chang, C., et al. (2001). Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: Comparison of self-report and electronic monitoring. Clinical Infectious Diseases, 33, 1417-1423.
2. Bangsberg, D.R., Bronstone, A., & Hofmann, R. (2002). A computer-based assessment detects regimen misunderstandings and non-adherence for patients on HIV antiretroviral therapy. AIDS Care, 14, 3-15.
3. Bangsberg, D.R., Hecht, F.M., Charlebois, E.D., Zolopa, A.R., Holodniy, M., Sheiner, L., et al. (2000). Adherence to protease inhibitors, HIV-1 viral load and development of drug resistance in an indigent population. AIDS, 14, 357-366.
4. Bangsberg, D.R., Perry, S., Charlebois, E.D., Clark, R.A., Roberston, M., Zolopa, A.R., & Moss, A. (2001). Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS, 15, 1181-1183.
5. Besch, C.L. (1995). Compliance in clinical trials. AIDS, 9, 1-10.
6. Carrieri, M.P., Raffi, F., Lewden, C., Sobel, A., Michelet, C., Cailleton, V., et al. (2003). Impact of early versus late adherence to highly active antiretroviral therapy on immunovirological response: A 3-year follow-up study. Antiviral Therapy, 8, 585-594.
7. Carrieri, P., Cailleton, V., Le Moing, V., Spire, B., Dellamonica, P., Bouvet, E., et al. (2001). The dynamic of adherence to highly active antiretroviral therapy: Results from the French National APROCO cohort. Journal of Acquired Immune Deficiency Syndromes, 28, 232-239.
8. Chesney, M.A., Ickovics, J.R., Chambers, D.B., et al. (2000). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG Adherence Instruments. AIDS Care, 12, 255-266.
9. Cohn, S.E., Kammann, E., Williams, P., Currier, J.S., & Chesney, M.A. (2002). Association of adherence to Mycobacterium avium complex prophylaxis and antiretroviral therapy with clinical outcomes in acquired immunodeficiency syndrome. Clinical Infectious Diseases, 34, 1129-1136.
10. Cramer, J.A., Scheyer, R.D., & Mattson, R.H. (1990). Compliance declines between clinic visits. Archives of Internal Medicine, 150, 1509-1510.
11. Cramer, J.A., Mattson, R.H., Prevey, M.L., Scheyer, R.D., & Ouellette, V.L. (1989). How often is medication taken as prescribed? A novel assessment technique. Journal of the American Medical Association, 261, 3273-3277.
12. Fletcher, S.W., Pappius, E.M., & Harper, S.J. (1979). Measurement of medication compliance in a clinical setting. Archives of Internal Medicine, 139, 635-638.
13. Giordano, T.P., Guzman, D., Clark, R., Charlebois, E.D., & Bangsberg, D.R. (2004). Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale. HIV Clinical Trials, 5, 74-79.
14. Ickovics, J.R., Cameron, A., Zackin, R., Bassett, R., Chesney, M., Johnson, V.A., et al. (2002). Consequences and determinants of adherence to antiretroviral medication: Results from Adult AIDS Clinical Trials Group protocol 370. Antiviral Therapy, 7, 185-193.
15. Knobel, H., Alonso, J., Casado, J.L., Collazos, J., Gonzalez, J., Ruiz, et al. (2002). Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: The GEEMA Study. AIDS, 16, 605-613.
16. Lawrence, J., Mayers, D.L., Huppler Hullsiek, K., Collins, G., Abrams, D.I., Reisler, R.B., et al. (2003). Structured treatment interruption in patients with multidrug-resistant human immunodeficiency virus. New England Journal of Medicine, 349, 837-846.
17. Lawrence, J., Huppler Hullsiek, K., Thackeray, L.M., Abrams, D.I., Crane, L.R., Mayers, D.L., et al. (2006). Disadvantages of structured treatment interruption persist in patients with multi-drug-resistant HIV-1. Final Results of the CPCRA 064 Study. Journal of Acquired Immune Deficiency Syndromes, 43, 169-178.
18. Liu, H., Golin, C.E., Miller, L.G., Hays, R.D., Beck, C.K., Sanandaji, S., et al. (2001). A comparison study of multiple measures of adherence to HIV protease inhibitors. Annals of Internal Medicine, 134, 968-977.
19. Mannheimer, S., Friedland, G., Matts, J., Child, C., & Chesney, M. (2002). The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials. Clinical Infectious Diseases, 34, 1115-1121.
20. Mannheimer, S.B., Matts, J., Telzak, E., Chesney, M., Child, C., Wu, A.W., et al. (2005). Quality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherence. AIDS Care, 17, 10-22.
21. Mannheimer, S.B., Mukherjee, R., Hirschhorn, L.R., Dougherty, J., Celano, S.A., Ciccarone, D., et al. (2006). The CASE adherence index: A novel method for measuring adherence to antiretroviral therapy. AIDS Care, 18, 853-861.
22. Nieuwkerk, P., & Oort, F.J. (2005). Self-reported adherence to antiretroviral therapy for HIV-1 infection and virologic treatment response: A meta-analysis. Journal of Acquired Immune Deficiency Syndromes, 38, 445-448.
23. Nieuwkerk, P., Gisolf, E., Sprangers, M., & Danner, S. (2001). Adherence over 48 weeks in an antiretroviral clinical trial: Variable within patients, affected by toxicities and independently predictive of virological response. Antiviral Therapy, 6, 97-103.
24. Oyugi, J.H., Byakika-Tusiime, J., Charlebois, E.D., Kityo, C., Mugerwa, R., Mugyenyi, P., et al. (2004). Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting. Journal of Acquired Immune Deficiency Syndrome, 36, 1100-1102.
25. Rand, C.S., Wise, R.A., Nides, M., Simmons, M.S., Bleecker, E.R., Kusek, J.W., et al. (1992). Metered-dose inhaler adherence in a clinical trial. American Reviews of Respiratory Diseases, 146, 1559-1564.
26. Simoni, J.M., Kurth, A.E., Pearson, C.R., Pantalone, D.W., Merrill, J.O., & Frick, P.A. (2006). Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management. AIDS and Behavior, 10, 227-245.
27. Wagner, G.J. (2002). Predictors of antiretroviral adherence as measured by self-report, electronic monitoring and medication diaries. AIDS Patient Care and STDS, 16, 599-608.
28. Walsh, J.C., Mandlia, S., & Gazzard, B.G. (2002). Responses to a 1-month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome. AIDS, 16, 269-277.
29. Waterhouse, D.M., Calzone, K.A., Mele, C., & Brenner, D.E. (1993). Adherence to oral tamoxifen: A comparison of patient self-report, pill counts, and microelectronic monitoring. Journal of Clinical Oncology, 11, 1189-1197.